Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPSB-SD vs VP-VI in Anticoagulated Patients Undergoing Cardiac Surgery
NCT00151853Phase 4Completed
- Sponsor
- Prothya Biosolutions
- Start
- Mar 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prothrombin complex concentrate (human) (2 arms), sponsored by Prothya Biosolutions. Primary endpoint: Time to reach target INR of ≤1.5 after the end of CPB. Started Mar 2002; status: completed.
02
Drugs
prothrombin complex concentrate (human)
Beyond the preview
Go deeper on NCT00151853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151853.